¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sodium carrier"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • sodium dodecyl sulfate
    ¼Òµð¿òµµµ¥½Ç¼³ÆäÀÌÆ®
  • sodium excreting factor
    ³ªÆ®·ý¹è¼³ÀÎÀÚ (¡­ÛÉàÜì×í­).
  • sodium fluoride
    ºÒÈ­³ªÆ®·ý
  • sodium hippurate hydrolysis test
    È÷Ǫ¸£»ê[¸¶´¢»ê]³ªÆ®·ý °¡¼öºÐÇØ½ÃÇè
  • sodium hydroxide
    ¼ö»êÈ­³ªÆ®·ý
  • sodium iodide
    ¿äµåÈ­³ªÆ®·ý
  • sodium lactate solution, Hartmann
    Á£»ê³ªÆ®·ý¿ë¾×, Çϸ£Æ®¸¸¿ë¾×, À¯»ê³ªÆ® ·ý¿ë¾×.
  • sodium load
    ³ªÆ®·ýºÎÇÏ(·®)(¡­Ý¶ùÃåÖ).
  • sodium nitroprusside
    ¼Òµð¿ò´ÏÆ®·ÎÇÁ·ç½Ãµå
  • sodium oxalate
    ¿Á»ì»ê³ªÆ®·ý
  • sodium polyanethol sulfonate
    ¼Òµð¿òÆú¸®¾Æ³×Åç¼³Æ÷³×ÀÌÆ®
  • sodium pump
    ³ªÆ®·ýÆßÇÁ.
  • sodium pump theory
    ³ªÆ®·ýÆßÇÁ¼³(¡­æò).
  • sodium reabsorption
    ¼Òµð¿ò[³ªÆ®·ý] ÀçÈí¼ö
  • sodium space
    ³ªÆ®·ýºÐÆ÷°ø°£(¡­ÝÂøÖÍöÊà).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
C/N carbon/nitrogen [ratio]; carrier/ noise [ratio]
CTh carrier-specific T-helper [cell]
EAAC excitatory amino acid carrier
PCC Pasteur Culture Collection; percutaneous cecostomy; pheochromocytoma; phosphate carrier compound; pl...
RCP red cell protoporphyrin; retrocorneal pigmentation; riboflavin carrier protein; Royal College of Phy...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
RCP Riboflavin carrier protein
SCAMP secretory carrier membrane protein
SCP-2 Sterol Carrier Protein 2
SCP Sterol Carrier Proteins
SCPx Sterol carrier protein X
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sodium bisulfite
    Áß¾ÆÈ²»ê ³ªÆ®·ý
    ¾ÆÈ²»ê ¼ö¼Ò ³ªÆ®·ý. ¿©·¯ °¡ÁöÀÇ Á¦¾à¿¡ Ç×»êÈ­Á¦·Î »ç¿ëµÈ´Ù.
  • sodium carbonate
    ź»ê ³ªÆ®·ý
    ¹«»öÀÇ °áÁ¤ ¶Ç´Â ¹é»öÀÇ °áÁ¤¼º ºÐ¸». Á¦¾×¿¡¼­ ¾ËÄ®¸®È­ ¾àǰÀ¸·Î »ç¿ëÇÑ´Ù. ¶ÇÇÑ Àμ³À» ÀÏÀ¸Å°´Â ÇǺκ´ÀÇ Ä¡·á¿¡ »ç¿ëÇϸç, ¼¼Á¤Á¦·Îµµ ¾²ÀδÙ.
  • sodium citrate
    ±¸¿¬»ê ³ªÆ®·ý
    C6H5Na3O7. ±¸¿¬»êÀÇ »ï³ªÆ®·ý¿°.
  • sodium exchange resin
    ³ªÆ®·ý ±³È¯ ¼öÁö, ¼Òµð¿ò ±³È¯ ¼öÁö
  • sodium fluoride denitifrice
    ºÒÈ­ ³ªÆ®·ý Ä¡¾à
  • sodium glutamate
    ±Û·çŸ¹Î»ê ³ªÆ®·ý
    ¾Æ¹Ì³ë»êÀÇ ÇϳªÀÎ L-±Û·çŸ¹Î»êÀÇ ³ªÆ®·ý¿°. ÁÁÀº ¸ÀÀ» Áö³à Á¶¹Ì·á·Î¼­ Àß ¾Ë·ÁÁ® ÀÖ´Ù. D-ü´Â Ưº°ÇÑ ¸ÀÀ» Áö´Ï°í ÀÖÁö ¾Ê´Ù. l-±Û·çŸ¹Î»êÀº ³ú ´ë»ç¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç ¾Ï¸ð´Ï¾Æ¿Í °áÇÕÇØ ±Û·çŸ¹ÎÀÌ µÇ¹Ç·Î ÀúÇ÷´ç È¥¼ö, °£¼º È¥¼ö ½Ã³ª ¾Ï¸ð´Ï¾Æ ÇØµ¶¿¡ »ç¿ëÇÑ´Ù. ´Ù·® »ç¿ë ½Ã¿¡´Â ¾ËÄ®·Î½Ã½º, ¿À½É, ±¸Åä, µÎºÎ ¾Ð¹Ú°¨, µÎÅë µîÀÌ ³ªÅ¸³ª´Â ¼ö°¡ ÀÖ´Ù. À̰ÍÀº Á¶¹Ì·á¸¦ ´Ù·® »ç¿ëÇÏ´Â ÁßÈ­ ¿ä¸®¸¦ ¸ÔÀº µÚ¿¡ ÀϾ´Â Á¡¿¡¼­ ÁßÈ­ ¿ä¸®Á¡ ÁõÈıº
  • sodium hydroxide
    ¼ö»êÈ­ ³ªÆ®·ý
    ¹é»öÀÇ °íü. ÀÛ°í µÕ±Ù ¸ð¾ç, ¹ÚÆí ¸ð¾ç, ¸·´ë ¸ð¾ç µî ¿©·¯ ¸ð¾çÀ¸·Î Á¸ÀçÇÑ´Ù. °­ÇÑ ¾ËÄ®¸®¼º. Á¦¾×¿¡¼­ ¾ËÄ®¸®È­Á¦·Î »ç¿ëÇÑ´Ù.
  • sodium hypochlorite
    Â÷¾Æ¿°¼Ò»ê ³ªÆ®·ý
  • sodium lauryl sulfate
    ¶ó¿ì¸± Ȳ»ê ³ªÆ®·ý
    À½À̿ ǥ¸é Ȱ¼ºÁ¦. ¹é»ö ¶Ç´Â ¹àÀº Ȳ»öÀÇ °áÁ¤. ½ÀÀ±Á¦, À¯È­ º¸Á¶Á¦, °¢Á¾ ¹Ì¿ë°ú ÇǺο¡ ´ëÇÑ ¼¼Á¤Á¦, Å©¸² Ä¡¾àÀÇ ¼ººÐÀ¸·Î »ç¿ëÇÑ´Ù.
  • sodium monofluorophosphate
    ÀÏ ºÒ¼Ò ÀÎ»ê ³ªÆ®·ý
    µ¿ÀǾî=
  • sodium nitrate
    ¾ÆÁú»ê ³ªÆ®·ý
    ¹é»öÀ̳ª ¾à°£ ³ë¶õ»öÀÇ °ú¸³¼º ºÐ¸», ¹é»öÀÇ ºÒÅõ¸íÇÑ ¿ëÀ¶ µ¢¾î¸® ¶Ç´Â ¸·´ë ¸ð¾ç. û»ê Ä®¸® Áßµ¶¿¡ ´ëÇÑ ÇØµ¶Á¦·Î »ç¿ëÇÑ´Ù. Çù½ÉÁõ, õ½ÄÀÇ °æ¿ì¿¡µµ »ç¿ëµÇ¸ç, º¹Åë, °æ·Ã¼º ´ëÀå¿°°ú °°Àº »óÅ¿¡µµ ÀÌ¿ëµÇ°í ÀÖ´Ù.
  • sodium perborate
    °úºØ»ê ³ªÆ®·ý
    ºØ»êÀ̳ª ºØ»ê³ªÆ®·ýÀÌ ³ªÆ®·ý ¶Ç´Â °ú»êÈ­ ¼ö¼Ò¿Í »óÈ£ÀÛ¿ëÇÏ¿© »ý¼ºµÈ È­ÇÕ¹°, ¹æºÎÁ¦. 2% ¿ë¾×À¸·Î´Â ¾çÄ¡Áú ¾×À¸·Îµµ »ç¿ëµÈ´Ù.
  • sodium phosphate
    ÀÎ»ê ³ªÆ®·ý
    µ¿ÀǾî=disodium hydrogen
  • sodium polystyrene sulfonate
    Æú¸®½ºÅ¸À̸° ¼³Æù ³ªÆ®·ý
    ³ªÆ®·ý ÇüÅÂÀÇ ¾çÀ̿ ±³È¯ ¼öÁö 1g´ç ¹«¼ö±âÀÇ Ä®·ý 110-135mg °ú ±³È¯. °úÄ®·ý Ç÷Áß Ä¡·á¿¡ »ç¿ëÇÑ´Ù.
  • sodium pump
    ³ªÆ®·ý ÆßÇÁ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
3-oxoacyl-(acyl-carrier-protein) synthase <enzyme> An enzyme of long-chain fatty acid synthesis, that adds a two-carbon unit from malonyl-(acyl carrier protein) to another molecule of fatty acyl-(acyl carrier protein), giving a beta-ketoacyl-(acyl carrier protein) with the release of carbon dioxide.
Chemical name: Acyl-(acyl carrier protein):malonyl-(acyl-carrier-protein) C-acyltransferase (decarboxylating)
Registry number: EC 2.3.1.41
(12 Dec 1998)
latent carrier A person, typically a prospective parent, bearing the appropriate genotype of a trait (homozygous for recessive, homozygous or heterozygous for dominant, hemizygous or homozygous for X-linked) that manifests the trait only under certain conditions, e.g., age, an environmental insult, etc.
(05 Mar 2000)
long-chain-fatty-acid-(acyl-carrier-protein) ligase <enzyme> Fatty acid, acyl-carrier-protein-sh and ATP gives acyl-(acyl-carrier-protein), AMP and ppi
Registry number: EC 6.2.1.20
Synonym: fatty acid-acyl carrier protein ligase (AMP), acyl-(acyl-carrier-protein)synthetase, aacp synthetase, fatty acyl-acyl carrier protein synthase, vibrio harveyi, acyl-(acyl-carrier-protein) synthetase, acyl-acp synthetase
(26 Jun 1999)
acetosulfone sodium 2-N-Acetylsulfamyl-4,4'-diaminodiphenylsulfone;a leprostatic administered orally.
(05 Mar 2000)
acetrizoate sodium Salt of 3-acetamido-2,4,6-triiobenzoic acid, a formerly used water-soluble radiographic contrast medium.
(05 Mar 2000)
antimony sodium gluconate <chemical> Antimony complex where the metal may exist in either the pentavalent or trivalent states. The pentavalent gluconate is used in leishmaniasis. The trivalent gluconate is most frequently used in schistosomiasis.
Pharmacological action: antiprotozoal agents, schistosomicides.
(12 Dec 1998)
antimony sodium tartrate Na(SbO)C4H4O6;used in the treatment of schistosomiasis, and as an emetic.
Synonym: sodium antimonyl tartrate.
(05 Mar 2000)
antimony sodium thioglycollate A compound of antimony trioxide and thioglycolic acid, used for tropical parasites.
(05 Mar 2000)
azlocillin sodium Sodium (6R)-6-[d-2-(2-oxoimidazolidine-1-carboxamido)-2-phenylacetamido]penicillanate;an extended spectrum penicillin used in treatment of infections caused by Pseudomonas aeruginosa, Escherichia coli, and Haemophilus influenzae.
(05 Mar 2000)
bismuth sodium tartrate A basic sodium bismuth tartrate; an antisyphilitic agent.
(05 Mar 2000)
bismuth sodium triglycollamate Sodium bismuth complex of nitrilotriacetic acid.
(05 Mar 2000)
caffeine and sodium benzoate A mixture of equal parts of sodium benzoate and caffeine, used to meet the indication of caffeine.
(05 Mar 2000)
caffeine and sodium salicylate A mixture of sodium salicylate and caffeine used for the relief of headache and neuralgia.
(05 Mar 2000)
meclofenamate sodium Monosodium N-(2,6-dichloro-m-tolyl)anthranilate monohydrate;a non-steroidal anti-inflammatory agent with analgesic and antipyretic actions.
(05 Mar 2000)
cefoperazone sodium C25H26N9NaO8S2;a semisynthetic piperazine-cephalosporin antibiotic.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • minority carrier
    ¼Ò¼ö´ãü(¹ÝµµÃ¼ÀÇ)
  • personnel carrier
    ±º¼ö¼ÛÂ÷ 
  • torpedo carrier (plane)
    ³ú°Ý±â
  • troop carrier
    ±º´ë ¼ö¼Û±â(Â÷)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á